Financials

News Ideas Minds Technicals

399 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to INNOVATIVE PHARMACEUTICAL BIOTECH L operating, investing, and financing activities

399 free cash flow for H1 23 is -4.38 M HKD. For 2022, 399 free cash flow was -17.64 M HKD and operating cash flow was -17.64 M HKD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—